Allscripts Healthcare Solutions Inc. (MDRX): Price and Financial Metrics

Allscripts Healthcare Solutions Inc. (MDRX): $17.05

0.17 (+1.01%)

POWR Rating

Component Grades














  • MDRX scores best on the Growth dimension, with a Growth rank ahead of 99.74% of US stocks.
  • MDRX's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • MDRX's current lowest rank is in the Momentum metric (where it is better than 38.1% of US stocks).

MDRX Stock Summary

  • With a year-over-year growth in debt of 53.36%, Allscripts Healthcare Solutions Inc's debt growth rate surpasses 84.24% of about US stocks.
  • As for revenue growth, note that MDRX's revenue has grown 0.02% over the past 12 months; that beats the revenue growth of only 18.38% of US companies in our set.
  • Allscripts Healthcare Solutions Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 9.4%, greater than the shareholder yield of 83.09% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Allscripts Healthcare Solutions Inc are RNWK, CSGS, EBS, FSLR, and WB.
  • Visit MDRX's SEC page to see the company's official filings. To visit the company's web site, go to

MDRX Valuation Summary

  • In comparison to the median Technology stock, MDRX's price/sales ratio is 73.58% lower, now standing at 1.4.
  • MDRX's price/sales ratio has moved down 1.3 over the prior 243 months.
  • MDRX's price/sales ratio has moved down 1.3 over the prior 243 months.

Below are key valuation metrics over time for MDRX.

Stock Date P/S P/B P/E EV/EBIT
MDRX 2021-09-01 1.4 1.4 2.6 2.9
MDRX 2021-08-31 1.4 1.4 2.5 2.9
MDRX 2021-08-30 1.4 1.4 2.5 2.9
MDRX 2021-08-27 1.4 1.4 2.6 3.0
MDRX 2021-08-26 1.3 1.4 2.5 2.9
MDRX 2021-08-25 1.4 1.4 2.6 2.9

MDRX Growth Metrics

    The 3 year price growth rate now stands at -21.1%.
  • Its 3 year cash and equivalents growth rate is now at 47.68%.
  • The 5 year price growth rate now stands at -51.59%.
Over the past 15 months, MDRX's revenue has gone down $172,913,000.

The table below shows MDRX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,503.037 -75.428 134.438
2021-09-30 1,389.072 -319.092 774.987
2021-06-30 1,421.83 -322.015 759.349
2021-03-31 1,454.339 -98.432 729.818
2020-12-31 1,502.7 -106.715 700.407
2020-09-30 1,675.95 84.215 -46.387

MDRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MDRX has a Quality Grade of C, ranking ahead of 38.48% of graded US stocks.
  • MDRX's asset turnover comes in at 0.496 -- ranking 62nd of 83 Computers stocks.
  • INVE, CLSK, and DGII are the stocks whose asset turnover ratios are most correlated with MDRX.

The table below shows MDRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.496 0.384 1.040
2021-03-31 0.480 0.384 0.931
2020-12-31 0.481 0.376 0.725
2020-09-30 0.524 0.396 -0.018
2020-06-30 0.534 0.394 -0.025
2020-03-31 0.544 0.397 -0.172

MDRX Price Target

For more insight on analysts targets of MDRX, see our MDRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $17.86 Average Broker Recommendation 1.79 (Moderate Buy)

MDRX Stock Price Chart Interactive Chart >

Price chart for MDRX

MDRX Price/Volume Stats

Current price $17.05 52-week high $23.25
Prev. close $16.88 52-week low $13.05
Day low $16.54 Volume 1,752,500
Day high $17.28 Avg. volume 1,820,313
50-day MA $20.81 Dividend yield N/A
200-day MA $17.93 Market Cap 1.98B

Allscripts Healthcare Solutions Inc. (MDRX) Company Bio

AllScripts Healthcare Solutions provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The company was founded in 1986 and is based in Chicago, Illinois.

MDRX Latest News Stream

Event/Time News Detail
Loading, please wait...

MDRX Latest Social Stream

Loading social stream, please wait...

View Full MDRX Social Stream

Latest MDRX News From Around the Web

Below are the latest news stories about Allscripts Healthcare Solutions Inc that investors may wish to consider to help them evaluate MDRX as an investment opportunity.

Allscripts Announces Fourth Quarter and Fiscal Year 2021 Results

CHICAGO, February 24, 2022--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and twelve months ended December 31, 2021.

Yahoo | February 24, 2022

Allscripts Healthcare Solutions Q4 2021 Earnings Preview (NASDAQ:MDRX)

Allscripts Healthcare Solutions (NASDAQ:MDRX) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $0.32 (+10.3%…

Seeking Alpha | February 23, 2022

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

Investors continue to be optimistic about BD (BDX) owing to its slew of regulatory approvals and strategic deals.

Yahoo | February 23, 2022

2022 Statistics: Digital Health Market Will Surpass $430.52 Billion at 16.9% CAGR Growth: Vantage Market Research

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Digital health technology is designed to provide patients new method of healthcare system. This system includes concepts for saving time, boosting accuracy and cost efficiency to manage illness, health risks and promote wellness. Digital health, or digital healthcare, is a broad, multidisciplinary concept that includes concepts from an intersection between technology and healthcare. Digital health applies digital transformation to the healthcare field, incorporating software, hardware and services. These enhanced capabilities of digital health technology are expected to generate revenue in coming years, states Vantage Market Research, in a report, titled " Digital Health Market by Technology (Telehealthcare, mHealth, Healthacare Analytics, D...

Benzinga | February 21, 2022

Fulgent Genetics (FLGT) to Post Q4 Earnings: What's in Store?

In terms of COVID-19 NGS revenues, Fulgent Genetics (FLGT) is expected to have witnessed a rise in testing volume on increased demand through the Q4 months.

Yahoo | February 21, 2022

Read More 'MDRX' Stories Here

MDRX Price Returns

1-mo -22.04%
3-mo -16.18%
6-mo 2.77%
1-year 2.77%
3-year 67.32%
5-year 49.82%
YTD -7.59%
2021 27.77%
2020 47.12%
2019 1.82%
2018 -33.75%
2017 42.51%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5675 seconds.